These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 20167848

  • 1. Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.
    Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG.
    Am J Respir Crit Care Med; 2010 Jun 15; 181(12):1383-90. PubMed ID: 20167848
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
    Hegmans JP, Hemmes A, Aerts JG, Hoogsteden HC, Lambrecht BN.
    Am J Respir Crit Care Med; 2005 May 15; 171(10):1168-77. PubMed ID: 15764728
    [Abstract] [Full Text] [Related]

  • 3. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells.
    Höltl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M.
    J Urol; 1999 Mar 15; 161(3):777-82. PubMed ID: 10022683
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ.
    Cancer Res; 2004 Jul 15; 64(14):4973-9. PubMed ID: 15256471
    [Abstract] [Full Text] [Related]

  • 5. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.
    Chang AE, Redman BG, Whitfield JR, Nickoloff BJ, Braun TM, Lee PP, Geiger JD, Mulé JJ.
    Clin Cancer Res; 2002 Apr 15; 8(4):1021-32. PubMed ID: 11948109
    [Abstract] [Full Text] [Related]

  • 6. Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.
    Cornelissen R, Hegmans JP, Maat AP, Kaijen-Lambers ME, Bezemer K, Hendriks RW, Hoogsteden HC, Aerts JG.
    Am J Respir Crit Care Med; 2016 May 01; 193(9):1023-31. PubMed ID: 26652184
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells.
    Matsumoto A, Haraguchi K, Takahashi T, Azuma T, Kanda Y, Tomita K, Kurokawa M, Ogawa S, Takahashi K, Chiba S, Kitamura T.
    Int J Urol; 2007 Apr 01; 14(4):277-83. PubMed ID: 17470153
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
    Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M, Tanaka R.
    Clin Cancer Res; 2005 Jun 01; 11(11):4160-7. PubMed ID: 15930352
    [Abstract] [Full Text] [Related]

  • 9. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep 01; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
    Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, Park KS, Lee IK, Chung IJ, Hwang TJ, Kim HJ.
    J Clin Apher; 2004 Sep 01; 19(2):66-70. PubMed ID: 15274198
    [Abstract] [Full Text] [Related]

  • 11. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD, Bellone S, Palmieri M, Ravaggi A, Romani C, Tassi R, Roman JJ, Burnett A, Pecorelli S, Cannon MJ.
    Gynecol Oncol; 2006 Mar 01; 100(3):469-78. PubMed ID: 16249018
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H, Zhou FJ, Wang QJ, Qin ZK, Huang LX, Liu ZW, Han H, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 May 01; 25(5):625-30. PubMed ID: 16687087
    [Abstract] [Full Text] [Related]

  • 13. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
    Ovali E, Dikmen T, Sonmez M, Yilmaz M, Unal A, Dalbasti T, Kuzeyli K, Erturk M, Omay SB.
    J Exp Clin Cancer Res; 2007 Jun 01; 26(2):209-14. PubMed ID: 17725100
    [Abstract] [Full Text] [Related]

  • 14. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009 Jun 01; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 15. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
    Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL.
    Cancer Res; 2001 Feb 01; 61(3):842-7. PubMed ID: 11221866
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naitoh K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K, Yamagishi H.
    Int J Oncol; 2004 Apr 01; 24(4):909-17. PubMed ID: 15010829
    [Abstract] [Full Text] [Related]

  • 17. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J, Chen M, Peng ML, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar 01; 13(3):198-201. PubMed ID: 15760555
    [Abstract] [Full Text] [Related]

  • 18. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients.
    Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJ.
    J Clin Oncol; 2003 Oct 15; 21(20):3826-35. PubMed ID: 14551301
    [Abstract] [Full Text] [Related]

  • 19. Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma.
    Powell A, Creaney J, Broomfield S, Van Bruggen I, Robinson B.
    Lung Cancer; 2006 May 15; 52(2):189-97. PubMed ID: 16563560
    [Abstract] [Full Text] [Related]

  • 20. Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.
    Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):869-77. PubMed ID: 16467101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.